MBBS (Hons), FCICM, FRACP, PGDipEcho Claire is a senior intensive care specialist, and became Director of ICU in 2020. Originally from Tasmania, Claire completed her medical degree in Hobart in 1999. After training at both The Alfred and Barwon Health, Claire began work as a Specialist in Barwon Health ICU in 2009. Major clinical projects include developing the Paediatric ICU program in University Hospital Geelong. Her work in this area was a significant factor in UHG being awarded the Victorian Premier’s Health Care Secretary Award for Improving Patient Outcomes and Patient Experience in 2014. Claire has a strong interest in education, having involvement with Deakin University, and ICU Supervisor of Training. Claire is also involved in Quality and Safety activities and is current Chair of the Blood and Blood Products Committee.

Clinical leadership
Claire became Director of Intensive Care at University Hospital Geelong in 2020. She has undertaken the Harvard Emerging Women Executives in Health Care Program, and is Chair of the Barwon Health Blood and Blood Products Committee, and led the development of the Barwon Health Paediatric Critical Care Program from 2011-2018.
-
Friday, February 19, 2021 - 07:30
JAMA RCT does not support use of single high dose oral vitamin D3 for treatment of moderate to severe COVID-19 in hospitalized patients. Limitations in design, however, confirms lack of benefit reported in multiple large non-COVID trials in hospital or ICU patients (VIOLET, VITdAL-ICU)
Sunday, February 14, 2021 - 09:30NEJM DePPaRT: 1% of patients with loss of cardiac activity after planned withdrawal of life sustaining therapy have transient resumption of cardiac activity observable by bedside reports and corroborated by ECG and IABP waveform activity. Retrospective waveform review showed resumption of cardiac activity in 14% of patients. The longest period of pulselessness that was followed by resumption of cardiac activity was 4 minutes 20 seconds.
Sunday, February 14, 2021 - 08:42JAMA OHCA sodium nitrite: Paramedic administration of 45mg or 60 mg sodium nitrite to patients with OHCA, vs placebo, did not improve survival to hospital admission, or secondary outcomes including survival or neurological recovery in 1502 adults in Seattle.King County. These findings do not support the use of sodium nitrite during resuscitation from out-of-hospital cardiac arrest.
Saturday, February 13, 2021 - 18:10NEJM: Dexmedetomidine vs Propofol for light-sedation in mechanically ventilated adults with sepsis, outcomes did not differ between.
Friday, February 12, 2021 - 18:50NEJM HOT-ICU Trial 2928 adults in ICU with acute hypoxaemic respiratory failure (mean P:F 118), an oxygen target of PaO2 60 mmHg vs 90 mmHg did not result in lower 90-d mortality, or secondary outcomes including mesenteric ischaemia and HIE